EMBC EMBECTA CORP

embecta to Participate in Investor Events

embecta to Participate in Investor Events

PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:

2025 Goldman Sachs Tenth Annual Leveraged Finance and Credit Conference

  • Management will host one-on-one investor meetings on Thursday, May 29, 2025, at Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA.

2025 Jefferies Global Healthcare Conference

  • Management will host a fireside session on Thursday, June 5, 2025, at 4:55 p.m. EDT, at the Marriott Marquis, New York City.

2025 Goldman Sachs 46th Annual Global Healthcare Conference

  • Management will host a fireside session on Tuesday, June 10, 2025, at 1:20 p.m. EDT, at the Loews Miami Beach Hotel, Miami, FL.

2025 Truist Securities MedTech Conference

  • Management will host one-on-one investor meetings on Tuesday, June 17, 2025, at the InterContinental, Boston, MA.

About embecta 

embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit or follow our social channels on , , and .

Contacts:

Media

Christian Glazar

Sr. Director, Corporate Communications

908-821-6922



Investors

Pravesh Khandelwal

VP, Head of Investor Relations

551-264-6547





EN
27/05/2025

Underlying

EMBCEMBECTA CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EMBECTA CORP

 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Participate in Investor Events

embecta to Participate in Investor Events PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events: 2025 Goldman Sachs Tenth Annual Leveraged Finance and Credit Conference Management will host one-on-one investor meetings on Thursday, May 29, 2025, at Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA. 2025 Jefferies Global Healthcare Con...

May 27, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta to Showcase Phased Approach for Value Creation and Present Lon...

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase its phased approach for value creation and present its long range financial plan (“LRP”). "Our Investor Day will provide a comprehensive view of our roadmap for transitioning embecta to growth. We look forward to shari...

May 22, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2025. "This quarter’s financial results were once again slightly ahead of our prior expectations, as our teams executed well, which included driving an acceleration in our free-cash flow generation, thereby allowing us to continue to repay debt and create additional balance sheet flexibility," said ...

May 9, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

embecta Announces Quarterly Cash Dividend

embecta Announces Quarterly Cash Dividend PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 13, 2025 to stockholders of record at the close of business on May 28, 2025. About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partne...

May 9, 2025 1 EN
 PRESS RELEASE
Free
EMBC EMBECTA CORP

Embecta to host Analyst and Investor Day on May 22, 2025

Embecta to host Analyst and Investor Day on May 22, 2025 PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in New York City. Dev Kurdikar, President & Chief Executive Officer, and Jake Elguicze, Chief Financial Officer, will be joined by members of the embecta leadership team to present strategic and business overview, including value creation opportunities, the company’s financial profi...

April 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch